150 related articles for article (PubMed ID: 1888818)
1. A controlled study of 20 mg famotidine nocte vs. 150 mg ranitidine nocte for the prevention of duodenal ulcer relapse.
Bianchi Porro G; Lazzaroni M; Barbara L; Corinaldesi R; Blasi A; Mangiameli A; Capurso L; Koch M; Cheli R; Bovero E
Aliment Pharmacol Ther; 1991 Apr; 5(2):181-9. PubMed ID: 1888818
[TBL] [Abstract][Full Text] [Related]
2. A multicentre, randomized, double-blind study comparing nocte famotidine or ranitidine for the treatment of active duodenal ulceration.
Alcalá Santaella R; Guardia J; Pajares J; Piqué J; Pita L; Alvárez E; Castellanos P; Guarner L; Ortiz J; Pesquera R
Aliment Pharmacol Ther; 1989 Feb; 3(1):103-10. PubMed ID: 2491454
[TBL] [Abstract][Full Text] [Related]
3. [Comparative efficacy of famotidine and ranitidine in the treatment of acute-phase duodenal ulcer. A French comparative therapeutic trial].
Delvaux M; Hagège CG; Ribet A
Gastroenterol Clin Biol; 1989 Dec; 13(12):1055-9. PubMed ID: 2696659
[TBL] [Abstract][Full Text] [Related]
4. Double-blind comparison of the safety and efficacy of famotidine with ranitidine in patients with endoscopically diagnosed peptic ulcer.
Sawant PD; Nanivadekar SA; Patel HD; Shroff CP; Oke VG; Jha RJ; Bowalekar SK; Navani SR; Raghu CN
J Assoc Physicians India; 1990 Sep; 38 Suppl 1():723-6. PubMed ID: 2092029
[TBL] [Abstract][Full Text] [Related]
5. Comparison of 40 mg famotidine nightly and 150 mg ranitidine b.d.: ulcer healing and symptom relief in benign gastric ulcer.
Cochran KM; Cockel R; Crowe J; Dickinson RJ; Gent AE; Kennedy NP; Royston CM; Cedar E; Mann SG
Aliment Pharmacol Ther; 1989 Oct; 3(5):461-70. PubMed ID: 2518859
[TBL] [Abstract][Full Text] [Related]
6. [Famotidine versus ranitidine in the acute treatment of duodenal ulcer. A multicenter comparative study in Germany].
Simon B; Dammann HG; Jakob G; Miederer SE; Müller P; Ottenjann R; Paul F; Scholten T; Schütz E; Seifert E
Z Gastroenterol; 1985 Feb; 23(2):47-51. PubMed ID: 2865859
[TBL] [Abstract][Full Text] [Related]
7. Comparison of once-daily bedtime administration of famotidine and ranitidine in the short-term treatment of duodenal ulcer. A multicenter, double-blind, controlled study.
Dobrilla G; De Pretis G; Piazzi L; Boero A; Camarri E; Crespi M; Fontana G; Ideo G; Manenti F; Marenco G
Scand J Gastroenterol Suppl; 1987; 134():21-8. PubMed ID: 2889255
[TBL] [Abstract][Full Text] [Related]
8. Famotidine vs ranitidine h.s. in acute duodenal ulcer. A multicentre endoscopic trial.
Bianchi Porro G; Lazzaroni M; Barbara L; Corinaldesi R; Blasi A; Mangiameli A; Capurso L; Koch M; Cheli R; Bovero E
Ital J Gastroenterol; 1991 Feb; 23(2):65-9. PubMed ID: 1747505
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for delayed healing of duodenal ulcers treated with famotidine and ranitidine.
Reynolds JC; Schoen RE; Maislin G; Zangari GG
Am J Gastroenterol; 1994 Apr; 89(4):571-80. PubMed ID: 8147361
[TBL] [Abstract][Full Text] [Related]
10. The efficacy and tolerability of famotidine and ranitidine on the healing of active duodenal ulcer and during six-month maintenance treatment, with special reference to NSAID/aspirin-related ulcers.
Bank S; Greenberg RE; Magier D; Lavin PT
Clin Ther; 1991; 13(2):304-18. PubMed ID: 1863945
[TBL] [Abstract][Full Text] [Related]
11. Famotidine in the short and long-term treatment of duodenal ulcer.
Zaterka S; de Paula Castro L; Villalobos JJ; Massuda HK; Eisig JN; Dias Avelar C; Coelho LG; Bettarello A
Acta Gastroenterol Latinoam; 1988; 18(2):115-21. PubMed ID: 3075106
[TBL] [Abstract][Full Text] [Related]
12. A multicenter, randomized, double-blind study comparing once-daily bedtime administration of famotidine and ranitidine in the short-term treatment of active duodenal ulcer.
Alcalá Santaella R; Guardia J; Pajares J; Pique J; Pita L; Alvárez E; Castellanos P; Guarner L; Ortiz J; Pesquera R
Hepatogastroenterology; 1989 Jun; 36(3):168-71. PubMed ID: 2666293
[TBL] [Abstract][Full Text] [Related]
13. A multicenter, randomized, double-blind study comparing famotidine with ranitidine in the treatment of active duodenal ulcer disease.
McCullough AJ
Am J Med; 1986 Oct; 81(4B):17-24. PubMed ID: 2877570
[TBL] [Abstract][Full Text] [Related]
14. 300 mg nizatidine at night versus 300 mg ranitidine at night in patients with duodenal ulcer. A multicentre trial in Europe.
Simon B; Cremer M; Dammann HG; Hentschel E; Keohane PP; Mulder H; Müller P; Sarles H
Scand J Gastroenterol Suppl; 1987; 136():61-70. PubMed ID: 2892257
[TBL] [Abstract][Full Text] [Related]
15. Review of an extensive worldwide study of a new H2-receptor antagonist, famotidine, as compared to ranitidine in the treatment of acute duodenal ulcer.
Bianchi Porro G; Dicenta C; Cook T; Humphries TJ
J Clin Gastroenterol; 1987; 9 Suppl 2():14-8. PubMed ID: 2887613
[TBL] [Abstract][Full Text] [Related]
16. A multicenter, randomized, double-blind study comparing a daily bedtime administration of famotidine and ranitidine in short-term treatment of active duodenal ulcer.
Alcalá-Santaella R; Guardia J; Pajares J; Piqué J; Pita L; Alvárez E; Castellanos P; Guarner L; Ortiz J; Pesquera R
Digestion; 1989; 42(2):79-85. PubMed ID: 2670647
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
Poynard T; Lemaire M; Agostini H
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):661-5. PubMed ID: 8590162
[TBL] [Abstract][Full Text] [Related]
18. [Comparison between ranitidine, famotidine, and omeprazole in the treatment of bleeding duodenal ulcer].
Maculotti L; Pradella P
Minerva Chir; 1995 Mar; 50(3):279-81. PubMed ID: 7659265
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic versus maintenance therapy in the prevention of duodenal ulcer recurrence. Results of a multicentric double-blind randomized trial.
Sobhani I; Chastang C; De Korwin JD; Lamouliatte H; Mégraud F; Guerre J; Elouaer-Blanc L
Gastroenterol Clin Biol; 1995 Mar; 19(3):252-8. PubMed ID: 7781936
[TBL] [Abstract][Full Text] [Related]
20. Lansoprazole versus famotidine: efficacy and tolerance in the acute management of duodenal ulceration.
Hotz J; Kleinert R; Grymbowski T; Hennig U; Schwarz JA
Aliment Pharmacol Ther; 1992 Feb; 6(1):87-95. PubMed ID: 1543819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
